Search
Returning search results with filters:
Remove filter for
Issue: Labelling
Remove filter for
Type: Alert
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 13 of 13 items.
A new presentation of SPIKEVAX (elasomeran) with a concentration of 0.10 mg/mL in a 2.5 mL multidose vial was authorized on June 01, 2022. In order to provide rapid access to the new presentation of SPIKEVAX (0.10 mg/mL, 2.5 mL multidose vial), Moderna…
AlertHealth professional risk communication | 2022-06-06
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…
AlertHealth professional risk communication | 2022-02-23
UPDATED INFORMATION - July 6, 2022
A new PAXLOVID dose pack for use in patients with moderate renal impairment (eGFR ≥30 to <60 mL/min) is now available with a distinct DIN: 02527804. Pfizer has introduced this new packaging configuration to…
AlertHealth professional risk communication | 2022-01-17
On December 23, 2021, Health Canada authorized a shelf-life extension, from 7 months to 9 months, for SPIKEVAX / COVID-19 Vaccine Moderna 5 mL vials. This 2-month extension may be retroactively applied to vials that are currently on the market with…
AlertHealth professional risk communication | 2022-01-11
UPDATED INFORMATION – October 29, 2021
Further to the Health Canada communications below issued on June 14, 2021 (and updated on June 24, 2021, and August 3, 2021), Health Canada has authorized a 2-month shelf life extension (from 7 months to 9 months…
AlertHealth professional risk communication | 2021-06-14
One lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream recalled because of a labelling error regarding use in children under two years of age
Starting date:…
AlertPublic advisory | 2019-12-23
Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
Starting date:
November 15…
AlertPublic advisory | 2019-11-15
Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21
Starting date:
June 12, 2019
Type of communication:
Advisory
Subcategory:…
AlertPublic advisory | 2019-06-12
One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error
Starting date:
December 21, 2018
Type of communication:…
AlertPublic advisory | 2018-12-21
Several children's strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles
Starting date:
November 14, 2018…
AlertPublic advisory | 2018-11-14
Several store-brand pain or sinus relief tablets recalled because consumers may be unable to access important safety information
Starting date:
November 7, 2018
Type of…
AlertPublic advisory | 2018-11-07
Sisu Inc. voluntarily recalls numerous natural health products because the glass bottles may contain glass fragments
Starting date:
February 22, 2018
Type of communication:…
AlertPublic advisory | 2018-02-22